Xconomy: Flu News, Articles and Opinions

“flu” Archives

Entry	Author	Date	Location
WI Watchlist: FluGen, Propeller Health, Gener8tor, EnSync	Jeff Engel	02/15/19	Wisconsin
NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial	Jeff Buchanan	09/19/18	Wisconsin
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines	Ben Fidler	08/16/18	New York
Bright Cellars, AmFam, Coinigy & More: This Week’s WI Watchlist	Jeff Buchanan	05/18/18	Wisconsin
FluGen to Study Versatility of Its Universal Flu Vaccine Candidate	Jeff Buchanan	05/17/18	Wisconsin
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge	Jeff Buchanan	05/01/18	Wisconsin
Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales	Jeff Buchanan	02/26/18	Wisconsin
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2)	Alex Lash	12/06/17	National
Fresh Off New Funding Round, FluGen Plans 3 Clinical Trials for 2018	Jeff Buchanan	08/04/17	Wisconsin
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs	Ben Fidler	02/10/17	Boston
Flu Research, Propeller, & Stem Cells: This Week’s WI Watchlist	Jeff Buchanan	05/31/16	Wisconsin
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq	Ben Fidler	06/16/15	Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile	Angela Shah	12/22/14	Texas
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More	Ben Fidler	10/06/14	Boston
WI-based FluGen Raises $3.4M For Universal Flu Vaccine Phase I Trial	Jeff Engel	06/02/14	Wisconsin
Myriad RBM Test Helping to Mine Secrets of Normal Immune System	Bernadette Tansey	04/16/14	Texas
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests	Jeff Engel	01/30/14	Wisconsin
Theraclone Merges With PharmAthene, Plans to Stay in Seattle	Luke Timmerman	08/01/13	Seattle
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health	Bernadette Tansey	03/15/13	Boston
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine	Luke Timmerman	08/16/12	Seattle
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus	Luke Timmerman	06/14/12	Seattle
Theraclone Passes First Clinical Test with Flu-Fighting Antibody	Luke Timmerman	05/15/12	Seattle
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO	Luke Timmerman	12/06/11	Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News	Luke Timmerman	09/29/11	Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News	Luke Timmerman	09/22/11	Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic	Luke Timmerman	09/21/11	Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu	Arlene Weintraub	04/28/11	New York
VBI Progressing with Vaccines That Don’t Require Refrigeration	Ryan McBride	03/24/11	Boston
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies	Luke Timmerman	03/08/11	Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections	Luke Timmerman	01/18/11	Seattle
Page 1 of 3	next page »